ARGENICA THERAPEUTICS LIMITED

ASX: AGN

Sector: Sector:Health Care
Industry group: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Latest AGN ASX Announcements

14 Aug 2026 · 3:32 amOther
Notification of cessation of securities - AGN
14 Aug 20263:32 amNotification of cessation of securities - AGNOther
27 July 2026 · 7:13 pmPresentations
Investor Presentation - Techknow Conference
27 July 20267:13 pmInvestor Presentation - Techknow ConferencePresentations
24 July 2026 · 7:18 pmQuarterly Reports
Quarterly Activities/Appendix 4C Cash Flow Report
24 July 20267:18 pmQuarterly Activities/Appendix 4C Cash Flow ReportQuarterly Reports
16 July 2026 · 6:27 pmCompany Update
ARG007 Shows Significant Neuroprotection in Concussion Study
16 July 20266:27 pmARG007 Shows Significant Neuroprotection in Concussion StudyCompany Update
11 June 2026 · 6:33 pmPresentations
Investor Webinar
11 June 20266:33 pmInvestor WebinarPresentations
11 June 2026 · 6:33 pmPresentations
Investor Presentation
11 June 20266:33 pmInvestor PresentationPresentations
11 June 2026 · 6:33 pmCompany Update
ARG007 (Xaranetide) Completes All Three FDA Requested Assays
11 June 20266:33 pmARG007 (Xaranetide) Completes All Three FDA Requested AssaysCompany Update
10 June 2026 · 6:19 pmCompany Update
WHO Confirms Xaranetide as INN for ARG-007
10 June 20266:19 pmWHO Confirms Xaranetide as INN for ARG-007Company Update
10 June 2026 · 12:13 amOther
Notification of cessation of securities - AGN
10 June 202612:13 amNotification of cessation of securities - AGNOther
26 May 2026 · 7:52 pmSecurities Administration
Release of Securities from Voluntary Escrow
26 May 20267:52 pmRelease of Securities from Voluntary EscrowSecurities Administration
21 May 2026 · 7:01 pmCompany Update
IND Application Advanced With Successful Completion of Assay
21 May 20267:01 pmIND Application Advanced With Successful Completion of AssayCompany Update
14 May 2026 · 7:15 pmCompany Update
Clinical Advisory Committee Established to Advance Phase 2b
14 May 20267:15 pmClinical Advisory Committee Established to Advance Phase 2bCompany Update
29 Apr 2026 · 6:20 pmQuarterly Reports
Quarterly Activities/Appendix 4C Cash Flow Report
29 Apr 20266:20 pmQuarterly Activities/Appendix 4C Cash Flow ReportQuarterly Reports
16 Apr 2026 · 7:15 pmPresentations
Investor Presentation - Ignite Conference
16 Apr 20267:15 pmInvestor Presentation - Ignite ConferencePresentations
26 Mar 2026 · 7:13 pmCompany Administration
Presentations at European Stroke Organisation Conference
26 Mar 20267:13 pmPresentations at European Stroke Organisation ConferenceCompany Administration

View complete AGN announcement history →